All Stories

  1. The Role of Age at Onset on the Clinical Course and Biochemical Parameters of Anorexia Nervosa
  2. Nutritional and Lifestyle Psychiatry: The Role of Nutrition and Lifestyle in the Onset, Prevention and Management of Mental Disorders
  3. Mediterranean Diet Compliance Is Related with Lower Prevalence of Perceived Stress and Poor Sleep Quality in University Students: A Cross-Sectional Study in Greece
  4. Exploring the Impact of Emotional Eating Among University Students: A Literature Review
  5. The Impact of the COVID-19 Pandemic in the Interrelationships Among Mental Health, Nutritional Status and Lifestyle Factors of Older Adults: A Cross-Sectional Study in the Pre- and Post-Covid Periods
  6. Body image distress and disordered eating among gay and straight men from Greece and Cyprus
  7. Body Weight and Food/Eating-Related Behaviors During the COVID-19 Pandemic or Other Traumatic or Stressful Life Events
  8. The COVID-19 Pandemic Increased the Risk of Eating Disorders and Emotional Eating Symptoms: A Review of the Current Clinical Evidence
  9. Altered Expression of Neuroplasticity-Related Genes in Alcohol Addiction and Treatment
  10. Overweight and Obesity Is Associated with Higher Risk of Perceived Stress and Poor Sleep Quality in Young Adults
  11. Clinical Factors Associated with Binge-Eating Episodes or Purging Behaviors in Patients Affected by Eating Disorders: A Cross-Sectional Study
  12. Could Insulin Be a Better Regulator of Appetite/Satiety Balance and Body Weight Maintenance in Response to Glucose Exposure Compared to Sucrose Substitutes? Unraveling Current Knowledge and Searching for More Appropriate Choices
  13. The Potential Effects of the Ketogenic Diet in the Prevention and Co-Treatment of Stress, Anxiety, Depression, Schizophrenia, and Bipolar Disorder: From the Basic Research to the Clinical Practice
  14. Evaluating the sociodemographic, anthropometric and lifestyle parameters, depression, quality of life, cognitive status, physical activity, and Mediterranean diet adherence of older adults in pre- and post-Covid-19 periods: a comparative cross-sectiona...
  15. Which Factors Are Associated With Comorbid Psychiatric Conditions in Patients Affected by Substance Use Disorders? The Impact of COVID-19 Pandemic on Dual-Diagnosis Subjects
  16. Association of Pregnant Women’s Perinatal Depression with Sociodemographic, Anthropometric and Lifestyle Factors and Perinatal and Postnatal Outcomes: A Cross-Sectional Study
  17. Clinical Evidence on the Potential Beneficial Effects of Diet and Dietary Supplements against COVID-19 Infection Risk and Symptoms’ Severity
  18. Associations between Mediterranean Diet Adherence, Quality of Life, and Mental Health in Patients with Multiple Sclerosis: A Cross-Sectional Study
  19. Association of Gestational Hypertension with Sociodemographic and Anthropometric Factors, Perinatal Outcomes, Breastfeeding Practices, and Mediterranean Diet Adherence: A Cross-Sectional Study
  20. The Impact of Clinical Factors, Vitamin B12 and Total Cholesterol on Severity of Anorexia Nervosa: A Multicentric Cross-Sectional Study
  21. Association of Mediterranean Diet Adherence with Disease Progression Characteristics, Lifestyle Factors and Overall Survival in Gastric Cancer Patients
  22. Association of COVID-19 Infection with Sociodemographic, Anthropometric and Lifestyle Factors: A Cross-Sectional Study in an Older Adults’ Population Aged over 65 Years Old
  23. Which clinical factors and biochemical parameters are associated with late-life major depression?
  24. Association of Mediterranean Diet Adherence with Sociodemographic, Anthropometric, and Lifestyle Factors during the COVID-19 Pandemic: A Cross-Sectional Study in Greece
  25. Are There Any Differences in Clinical and Biochemical Variables between Bipolar Patients with or without Lifetime Psychotic Symptoms?
  26. Postpartum Depression Is Associated with Maternal Sociodemographic and Anthropometric Characteristics, Perinatal Outcomes, Breastfeeding Practices, and Mediterranean Diet Adherence
  27. The Impact of the COVID-19 Pandemic on Binge Eating Disorder: A Systematic Review
  28. The Relationship of Ketogenic Diet with Neurodegenerative and Psychiatric Diseases: A Scoping Review from Basic Research to Clinical Practice
  29. Clinical Markers of Panic and Generalized Anxiety Disorder: Overlapping Symptoms, Different Course and Outcome
  30. Evaluating the Relationship between Circadian Rhythms and Sleep, Metabolic and Cardiovascular Disorders: Current Clinical Evidence in Human Studies
  31. The Association of Emotional Eating with Overweight/Obesity, Depression, Anxiety/Stress, and Dietary Patterns: A Review of the Current Clinical Evidence
  32. Clinical and Peripheral Biomarkers in Female Patients Affected by Anorexia: Does the Neutrophil/Lymphocyte Ratio (NLR) Affect Severity?
  33. Candidate Biological Markers for Social Anxiety Disorder: A Systematic Review
  34. COVID-19 Emotional and Mental Impact on Cancer Patients Receiving Radiotherapy: An Interpretation of Potential Explaining Descriptors
  35. Mapping the psychoanalytic literature on bipolar disorder: a scoping review of journal articles
  36. Probing the impact of psychoanalytic therapy for bipolar disorders: A scoping review
  37. Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports
  38. Health Care Workers During the COVID-19 Pandemic
  39. A virtual reality home-based training for the management of stress and anxiety among healthcare workers during the COVID-19 pandemic: study protocol for a randomized controlled trial
  40. Clinical and Biological Factors Are Associated with Treatment-Resistant Depression
  41. Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review
  42. Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review
  43. Consultation psychiatry in COVID ‐19 patients: Lopinavir/ritonavir interactions with main psychiatric drugs
  44. MIND-VR: Design and Evaluation Protocol of a Virtual Reality Psychoeducational Experience on Stress and Anxiety for the Psychological Support of Healthcare Workers Involved in the COVID-19 Pandemic
  45. Anxiety and Depression
  46. Global Storm of Stress-Related Psychopathological Symptoms: A Brief Overview on the Usefulness of Virtual Reality in Facing the Mental Health Impact of COVID-19
  47. Gulliver’s virtual travels: active embodiment in extreme body sizes for modulating our body representations
  48. The COVID-19 pandemic brings a second wave of social isolation and disrupted services
  49. Patient personality and psychotherapist reactions in individual psychotherapy setting: a systematic review
  50. Quality of life and psychopathology in candidates to bariatric surgery: relationship with BMI class
  51. Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms
  52. Virtual Reality
  53. Screening for postpartum depression and borderline personality disorder: Food for thought
  54. Electroencephalographic (EEG) alterations in young women with high subclinical eating pathology levels: a quantitative EEG study
  55. Tackling excess body weight in people with binge eating disorder
  56. Prevention of eating disorders: current evidence-base for dissonance-based programmes and future directions
  57. Cross-sectional study of neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in mood disorders
  58. Pattern of self-injurious behavior and suicide attempts in Italian custodial inmates: A cluster analysis approach
  59. Violence risk and mental disorders (VIORMED-2): A prospective multicenter study in Italy
  60. Problem-Gambling Severity, Suicidality, and DSM-IV Axis I Psychiatric Disorders
  61. Pathways to specialist care for eating disorders: An Italian multicentre study
  62. Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in non-affective psychosis: a meta-analysis and systematic review
  63. Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice
  64. Sex Differences in Adolescent Anorexia and Bulimia Nervosa: Beyond the Signs and Symptoms
  65. Adjunctive second-generation antipsychotics for specific symptom domains of schizophrenia resistant to clozapine: A meta-analysis
  66. Factors associated with referrals to high security forensic services among people with severe mental illness and receiving inpatient care in prison
  67. Being socially uninterested versus not having social prediction skills: The impact of multisensory integration deficits on social skills in autism
  68. Recent suicide attempts and serum lipid profile in subjects with mental disorders: A cross-sectional study
  69. Estimating the Risk of Attempted Suicide Among Sexual Minority Youths
  70. Testing the association of serum uric acid levels with behavioral and clinical characteristics in subjects with major affective disorders: A cross-sectional study
  71. Early Post-stroke Depression and Mortality: Meta-Analysis and Meta-Regression
  72. A Randomized Trial of Virtual Reality-Based Cue Exposure Second-Level Therapy and Cognitive Behavior Second-Level Therapy for Bulimia Nervosa and Binge-Eating Disorder: Outcome at Six-Month Followup
  73. Problem-gambling severity, suicidality and DSM-IV Axis II personality disorders
  74. The burden of personality disorders on the DSM 5 addiction to tobacco during pregnancy
  75. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis
  76. Vortioxetine overdose in a suicidal attempt
  77. The Role of Age on Multisensory Bodily Experience: An Experimental Study with a Virtual Reality Full-Body Illusion
  78. Purinergic system and suicidal behavior: exploring the link between adenosine A2A receptors and depressive/impulsive features
  79. Distinguishing Between Borderline Personality Disorder and Bipolar Disorder
  80. Evaluation of the DSM-5 severity ratings for anorexia nervosa in a clinical sample
  81. Impulsivity and Gambling Type Among Treatment-Seeking Disordered Gamblers: An Explorative Study
  82. Insomnia as an additional clinical correlate of suicidal ideation after stroke
  83. Testing the role of the antioxidant uric acid as a biomarker of suicidal ideation in subjects with major affective disorders: An exploratory study
  84. Altered Processing and Integration of Multisensory Bodily Representations and Signals in Eating Disorders: A Possible Path Toward the Understanding of Their Underlying Causes
  85. Are Treatment Outcomes Determined by Type of Gambling? A UK Study
  86. Effect of clinical response to active drugs and placebo on antipsychotics and mood stabilizers relative efficacy for bipolar depression and mania: A meta-regression analysis
  87. Classifying binge eating-disordered adolescents based on severity levels
  88. Neuroscience, Brain Imaging, and Body Image in Eating and Weight Disorders
  89. Virtual Reality for the Treatment of Body Image Disturbances in Eating and Weight Disorders
  90. Antidepressant Response and Dissociative Effects After Ketamine Treatment
  91. Personality and eating and weight disorders: an open research challenge
  92. Current suicidal ideation in treatment-seeking individuals in the United Kingdom with gambling problems
  93. The antioxidant uric acid and depression: clinical evidence and biological hypotheses
  94. Eating behavior style predicts craving and anxiety experienced in food-related virtual environments by patients with eating disorders and healthy controls
  95. Lipid profile and suicide attempt in bipolar disorder: A meta-analysis of published and unpublished data
  96. Egocentric and allocentric spatial reference frames in aging: A systematic review
  97. Severity of Binge-Eating Disorder and Its Effects on Treatment Outcome
  98. A Randomised Controlled Comparison of Second-Level Treatment Approaches for Treatment-Resistant Adults with Bulimia Nervosa and Binge Eating Disorder: Assessing the Benefits of Virtual Reality Cue Exposure Therapy
  99. Unblending Borderline Personality and Bipolar Disorders
  100. Progresses about the Interplay among Clarithromycin, Immune and Central Nervous Systems
  101. White matter abnormalities in treatment-naive adolescents at the earliest stages of Anorexia Nervosa: A diffusion tensor imaging study
  102. Testing virtual reality-based cue-exposure software: Which cue-elicited responses best discriminate between patients with eating disorders and healthy controls?
  103. Severity of bulimia nervosa and its impact on treatment outcome
  104. Risk and maintenance factors for young women’s DSM-5 eating disorders
  105. Alexithymia in parents and adolescents with generalised anxiety disorder
  106. Response to the best available treatment for bulimia nervosa and binge-eating disorder is disease severity-dependent
  107. Cognitive-behavioral or psychodynamic therapy for people with bulimia nervosa
  108. Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression
  109. The Italian Version of the Borderline Personality Disorder Severity Index IV: Psychometric Properties, Clinical Usefulness, and Possible Diagnostic Implications
  110. Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
  111. Acute variations of cytokine levels after antipsychotic treatment in drug-naïve subjects with a first-episode psychosis: A meta-analysis
  112. Bodily illusions and weight-related disorders: Clinical insights from experimental research
  113. Evaluation of the DSM-5 Severity Specifier for Bulimia Nervosa in Treatment-Seeking Youth
  114. Benefits and harms of low and high second-generation antipsychotics doses for bipolar depression: A meta-analysis
  115. Classifying Adults with Binge Eating Disorder Based on Severity Levels
  116. Purinergic dysfunction in bipolar disorder: Any role for the antioxidant uric acid as a trait and state biomarker?
  117. The nature of the association between binge-eating severity and metabolic syndrome
  118. Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
  119. Virtual Reality
  120. Association between total serum cholesterol and suicide attempts in subjects with major depressive disorder: Exploring the role of clinical and biochemical confounding factors
  121. Rates and correlates of suicidal ideation among stroke survivors: a meta-analysis
  122. Gambling Disorder: Exploring Pre-treatment and In-treatment Dropout Predictors. A UK Study
  123. Embodied Medicine: Mens Sana in Corpore Virtuale Sano
  124. Towards novel paradigms for treating dysfunctional bodily experience in eating disorders
  125. Validity and utility of the DSM-5 severity specifier for binge-eating disorder
  126. What about the assessment of personality disturbance in adolescents with eating disorders?
  127. Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders
  128. Purinergic system dysfunctions in subjects with bipolar disorder: A comparative cross-sectional study
  129. Allopurinol as add-on treatment for mania symptoms in bipolar disorder: Systematic review and meta-analysis of randomised controlled trials
  130. Neuroscientifically Informed Models of Body Image Distortion in Eating Disorders
  131. Self-Esteem and Eating Disorders
  132. “Nabucco” by Giuseppe Verdi: A Case of Delirium in an Italian Romantic Opera
  133. Social Standards of Beauty
  134. Virtual Reality
  135. Update on bipolar disorder biomarker candidates: what about uric acid/adenosine hypothesis?
  136. Agreement between DSM-IV and DSM-5 criteria for alcohol use disorder among outpatients suffering from depressive and anxiety disorders
  137. Stigmatizing Attitudes and Beliefs About Anorexia and Bulimia Nervosa Among Italian Undergraduates
  138. Area-Level Deprivation and Adverse Consequences in People With Substance Use Disorders: Findings From the Psychiatric and Addictive Dual Disorder in Italy (PADDI) Study
  139. Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?
  140. Uric acid levels in subjects with bipolar disorder: A comparative meta-analysis
  141. Testing the DSM-5 severity indicator for bulimia nervosa in a treatment-seeking sample
  142. Predicting onset and maintenance of men's eating disorders
  143. Mental health of prisoners: prevalence, adverse outcomes, and interventions
  144. Types of gambling and levels of harm: A UK study to assess severity of presentation in a treatment-seeking population
  145. Clinical utility of a single-item test for DSM-5 alcohol use disorder among outpatients with anxiety and depressive disorders
  146. Objectified Body Consciousness (OBC) in Eating Psychopathology
  147. Validity and clinical utility of the DSM-5 severity specifier for bulimia nervosa: results from a multisite sample of patients who received evidence-based treatment
  148. Pregnancy denial or concealement: A case report highlighting risks and forensic aspects
  149. Dysfunctional bodily experiences in anorexia nervosa: where are we?
  150. A Novel Technique for Improving Bodily Experience in a Non-operable Super–Super Obesity Case
  151. First-generation antipsychotics and QTc: any role for mediating variables?
  152. Gender Differences in Treatment-Seeking British Pathological Gamblers
  153. Exploring the association between bipolar disorder and uric acid: A mediation analysis
  154. Impact of a Mobile E-Health Intervention on Binge Drinking in Young People: The Digital–Alcohol Risk Alertness Notifying Network for Adolescents and Young Adults Project
  155. Body-image distortion in anorexia nervosa
  156. Predictors of initiation and persistence of recurrent binge eating and inappropriate weight compensatory behaviors in college men
  157. Prospective Psychosocial Predictors of Onset and Cessation of Eating Pathology amongst College Women
  158. Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval
  159. Virtual Reality Body Swapping: A Tool for Modifying the Allocentric Memory of the Body
  160. Association between depression and neuropathy in people with type 2 diabetes: a meta-analysis
  161. Disentangling the Association Between Child Abuse and Eating Disorders
  162. Neuroscientifically Informed Models of Body Image Distortion in Eating Disorders
  163. Self-Esteem and Eating Disorders
  164. Out of body, out of space: Impaired reference frame processing in eating disorders
  165. Facial emotion recognition in alcohol and substance use disorders: A meta-analysis
  166. Narcissistic Vulnerability and Grandiosity as Mediators Between Insecure Attachment and Future Eating Disordered Behaviors: A Prospective Analysis of Over 2,000 Freshmen
  167. The association between PTSD and metabolic syndrome: A role for comorbid depression?
  168. Posttraumatic Stress Disorder and Risk of Obesity
  169. Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study
  170. Second-generation antipsychotics and adiponectin levels in schizophrenia: A comparative meta-analysis
  171. Schizoaffective disorder and metabolic syndrome: A meta-analytic comparison with schizophrenia and other non-affective psychoses
  172. Transcranial magnetic stimulation of medial prefrontal cortex modulates implicit attitudes towards food
  173. Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: A meta-analysis
  174. The Social Appearance Anxiety Scale in Italian Adolescent Populations: Construct Validation and Group Discrimination in Community and Clinical Eating Disorders Samples
  175. Mechanisms of influence of body checking on binge eating
  176. Identifying specific cues and contexts related to bingeing behavior for the development of effective virtual environments
  177. Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders
  178. From DSM-IV to DSM-5 alcohol use disorder: An overview of epidemiological data
  179. Leveraging Psychology of Virtual Body for Health and Wellness
  180. Why do anorexics want to lose weight? This paper tries to explain why...
  181. Presence-Inducing Media for Mental Health Applications
  182. Factors characterizing access and latency to first pharmacological treatment in Italian patients with schizophrenia, mood, and anxiety spectrum disorders
  183. External Eating as a Predictor of Cue-reactivity to Food-related Virtual Environments
  184. Cannabis use disorder as a correlate of suicide attempts among people with bipolar disorder
  185. Testing the cognitive-behavioural maintenance models across DSM-5 bulimic-type eating disorder diagnostic groups: a multi-centre study
  186. The developmental effects of media-ideal internalization and self-objectification processes on adolescents’ negative body-feelings, dietary restraint, and binge eating
  187. Reply to Dakanalis et al.’s ‘efforts to make clearer the relationship between body dissatisfaction and binge eating’
  188. Cardiovascular risk factors among people with severe mental illness in Italy: A cross-sectional comparative study
  189. Testing the original and the extended dual-pathway model of lack of control over eating in adolescent girls. A two-year longitudinal study
  190. Attempted suicide in people with co-occurring bipolar and substance use disorders: Systematic review and meta-analysis
  191. Comorbid Addiction and Major Mental Illness in Europe: A Narrative Review
  192. Efforts to make clearer the relationship between body dissatisfaction and binge eating
  193. Risk Estimation Modeling and Feasibility Testing for a Mobile eHealth Intervention for Binge Drinking Among Young People: The D-ARIANNA (Digital-Alcohol RIsk Alertness Notifying Network for Adolescents and young adults) Project
  194. Why Do Only a Minority of Men Report Severe Levels of Eating Disorder Symptomatology, When so Many Report Substantial Body Dissatisfaction? Examination of Exacerbating Factors
  195. Body Dissatisfaction and Eating Disorder Symptomatology: A Latent Structural Equation Modeling Analysis of Moderating Variables in 18-to-28-Year-Old Males
  196. Natalizumab-related progressive multifocal leukoencephalopathy in Greece
  197. The prevalence of metabolic syndrome in people with severe mental illness: a mediation analysis
  198. Comprehensive examination of the trans-diagnostic cognitive behavioral model of eating disorders in males
  199. Attachment insecurities, maladaptive perfectionism, and eating disorder symptoms: A latent mediated and moderated structural equation modeling analysis across diagnostic groups
  200. Prevalence and Correlates of Binge Drinking among Young Adults Using Alcohol: A Cross-Sectional Survey
  201. Association between depression and non-fatal overdoses among drug users: A systematic review and meta-analysis
  202. Development of a VR Application for Binge Eating Treatment: Identification of Contexts and Cues Related to Bingeing Behavior in Spanish Italian Patients
  203. Virtual Reality for Improving Body Image Disorders and Weight Loss after Gastric Band Surgery: A Case Series
  204. Italian version of the Dutch Eating Behavior Questionnaire. Psychometric proprieties and measurement invariance across sex, BMI-status and age
  205. Metabolic Syndrome in People Suffering from Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis
  206. I’m in a virtual body: a locked allocentric memory may impair the experience of the body in both obesity and anorexia nervosa
  207. Psychosocial moderators of the relationship between body dissatisfaction and symptoms of eating disorders: A look at a sample of young Italian women
  208. Are the Male Body Dissatisfaction and Drive for Muscularity Scales reliable and valid instruments?
  209. Male body dissatisfaction and eating disorder symptomatology: Moderating variables among men
  210. Bipolar Disorder, Schizophrenia, and Metabolic Syndrome
  211. Current Findings on Males with Eating Disorders
  212. Psychiatric disorders encountered during bone marrow transplantation
  213. The role of body shame and body image avoidant behaviours in deliberate self-harm
  214. The impact of laparoscopic adjustable gastric banding on body image disturbance, self-esteem and psychological well-being: An Italian follow-up study
  215. The relationship of sex and sexual orientation to self-esteem, body shape satisfaction, and eating disorder symptomatology
  216. New Technologies for Improving the Psychological Treatment
  217. 2196 – The Association Between Body Image Issues And Women's Sexual Functioning Through The Lens Of The Objectification Theory
  218. 2131 – A Prospective Evaluation Of The Three-factor Interactive Model Of Bulimic Symptomatology Among Men
  219. 2814 – Body Image Dissatisfaction and Eating Disorder Symptomatology: a Latent Structural Equation Modeling Examination of Moderators Among Adolescent Girls
  220. 2811 – Personality and Body Image Disorders in Cosmetic Surgery Settings: Prevalence, Comorbidity and Evaluation of their Impact on Post-Operative Patient's Satisfaction
  221. 2199 – An Evaluation Of The Enhanced Cognitive-behavioural Model And Its Constructs As Moderators Of The Core Psychopathology Of Eating Pathology-bulimic Symptomatology Relationship
  222. 2195 – An Evaluation Of The Dual-pathway Model Of Binge Eating In Italian Adolescent Boys: a Longitudinal Structural Equation Modeling Approach
  223. Dutch Eating Behavior Questionnaire--Italian Version
  224. Depression after Stroke and Risk of Mortality: A Systematic Review and Meta-Analysis
  225. From Body Dissatisfaction to Obesity: How Virtual Reality May Improve Obesity Prevention and Treatment in Adolescents
  226. Perché è importante una federazione europea delle società delle tossicodipendenze?
  227. Il perché di un addio
  228. Pregabalin for Alcohol Dependence: A Critical Review of the Literature
  229. Disordered Eating Behaviors Among Italian Men: Objectifying Media and Sexual Orientation Differences
  230. The association between expressed emotion, illness severity and subjective burden of care in relatives of patients with schizophrenia. Findings from an Italian population
  231. Caratteristiche cliniche, sociodemografiche e criticità nella cura del paziente affetto da patologia mentale detenuto in Italia: studio osservazionale di casi consecutivi della durata di sei mesi
  232. Percorsi diagnostico-terapeutici per pazienti psichiatrici negli istituti penitenziari. Strategie dei Dipartimenti di Salute Mentale e delle Cliniche Psichiatriche Universitarie
  233. Trauma e disturbo post-traumatico da stress nella relazione con i disturbi mentali della popolazione carceraria minorile
  234. Do they actually work across borders? Evaluation of two measures of psychological distress as screening instruments in a non Anglo-Saxon country
  235. Utilizzo dell’elettroencefalografia nelle psicosi oggi
  236. Reducing the treatment gap for mental disorders: a WPA survey
  237. Gli eventi psichiatrici in corso di epilessia
  238. Clinical and genetic evaluation of a family showing both autism and epilepsy
  239. Bullismo e disturbo antisociale di personalità in adolescenza ed età giovanile
  240. Adolescenti e Psichiatria: una nuova direzione!
  241. Abuso e negligenza nell’anziano. Un problema contemporaneo
  242. Family interventions for schizophrenia in Italy: randomized controlled trial
  243. Expressed emotion and Milan systemic intervention: a pilot study on families of people with a diagnosis of schizophrenia
  244. Dual Diagnosis—Policy and Practice in Italy
  245. The Italian Association on Addiction Psychiatry (SIPDip), formerly The Italian Association on Abuse and Addictive Behaviours
  246. Cytokines production in chronic schizophrenia patients with or without paranoid behaviour
  247. Family Adaptation to Institutionalised Mentally Retarded Patients. A Preliminary Report on an Italian Population
  248. Personality Disorders among Psychoactive Substance Users: Diagnostic and Psychodynamic Issues
  249. Schizofrenia e intervento psicosociale sulle famiglie. Indagine sulle caratteristiche dell'utenza e follow-up ad un anno
  250. Alexithymia and Obesity
  251. Emotional Profiles of Families with a Heart-Operated Patient: A Pilot Study
  252. The Efficacy of an Information Group Intervention On Relatives of Schizophrenics
  253. Substance abuse and psychopathology
  254. Family Assessment and Linguistic Interaction: Analysis of the Camberwell Family Interview
  255. Involvement of families in group therapy of heroin addicts
  256. Representation of Psychosomatic Disturbances: Metaphor and Metonymy